LexDanaLexDanabeta
Inventor

William J. Watkins

Inventor
Saratoga, CA, US

Overview

78→
Patents
1992–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 78 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C07DHeterocyclic compounds26%
A61KPreparations for medical, dental or toiletry purposes24%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium11%
Y02ATechnologies for adaptation to climate change4%
C07HSugars2%
C07CAcyclic or carbocyclic compounds2%
C07BGeneral methods of organic chemistry1%
C07KPeptides1%
A01NPreservation of bodies of humans or animals or plants or parts thereof1%
PatentTitleYear
11,066,414Cot modulators and methods of use thereof202111,021,467Phosphatidylinositol 3-kinase inhibitors202110,988,451MCL-1 inhibitors202110,899,735PD-1/PD-L1 inhibitors202110,882,8514,6-di- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections202110,874,640Substituted pyrrolizine compounds and uses thereof202010,774,071PD-1/PD-L1 inhibitors202010,710,986PD-1/PD-L1 inhibitors202010,703,733MCL-1 inhibitors202010,577,352Cot modulators and methods of use thereof202010,479,770Phosphatidylinositol 3-kinase inhibitors201910,456,414Methods for treating HCV201910,328,053Substituted pyrrolizine compounds and uses thereof201910,316,049Tank-binding kinase inhibitor compounds201910,316,017COT modulators and methods of use thereof201910,259,811Tank-binding kinase inhibitor compounds201910,253,019Tank-binding kinase inhibitor compounds201910,238,636Methods of treating liver disease201910,221,197Phosphatidylinositol 3-kinase inhibitors201910,214,519Phosphatidylinositol 3-kinase inhibitors201910,144,736Substituted pteridines useful for the treatment and prevention of viral infections201810,092,563Phosphatidylinositol 3-kinase inhibitors201810,072,001Tank-binding kinase inhibitor compounds201810,059,695Cot modulators and methods of use thereof201810,040,781Tank-binding kinase inhibitor compounds201810,005,774Syk inhibitors20189,981,955Antiviral compounds20189,938,278FXR (NR1H4) modulating compounds20189,878,995'Cot modulators and methods of use thereof'20189,815,818'Cot modulators and methods of use thereof'20179,511,056'Antiviral compounds'20169,452,154'Methods for treating HCV'20169,376,441'Substituted pyrrolidines as SYK inhibitors'20169,321,753'Inhibitors of Flaviviridae viruses'20169,259,426'4,6-di- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections'20169,139,604'Antiviral phosphonate analogs'20158,927,741'Synthesis of an antiviral compound'20158,884,030'Inhibitors of Flaviviridae viruses'20148,871,785'Antiviral phosphonate analogs'20148,841,278'Antiviral compounds'20148,822,430'Antiviral compounds'20148,765,722'Inhibitors of flaviviridae viruses'20148,741,946'Inhibitors of flaviviridae viruses'20148,729,089'Pyrido(3,2-d)pyrimidines useful for treating viral infections'20148,673,929'4,6-di- and 2,4,6-trisubstituted quinazoline derivatives and pharmaceutical compositions useful for treating viral infections'20148,637,531'Pyrido(3,2-d)pyridmidines useful for treating viral infections'20148,575,118'Antiviral compounds'20138,569,302'Inhibitors of flaviviridae viruses'20138,536,187'2,4,6-trisubstituted pyrido(3,2-d)pyrimidines useful for treating viral infections'20138,524,764'Inhibitors of Flaviviridae viruses'20138,513,298'Inhibitors of flaviviridae viruses'20138,501,714'Inhibitors of Flaviviridae viruses'20138,435,969'Method and compositions for treating hematological malignancies'20138,338,435'Substituted pyrido(3,2-D) pyrimidines and pharmaceutical compositions for treating viral infections'20128,273,341'Antiviral compounds'20128,232,278'Pyrido(3,2-D)pyrimidines and pharmaceutical compositions useful for treating hepatitis C'20128,163,718'Nucleoside analogues containing phosphonate or phosphonamide groups'20128,143,394'Pyrido(3,2-d)pyrimidines useful for treating viral infections'20128,088,368'Antiviral compounds'20128,022,083'Antiviral phosphonate analogs'20117,645,747'Therapeutic phosphonate compounds'20107,470,724'Phosphonate compounds having immuno-modulatory activity'20087,452,901'Anti-cancer phosphonate analogs'20087,432,273'Phosphonate analogs of antimetabolites'20087,432,261'Anti-inflammatory phosphonate compounds'20087,429,565'Antiviral phosphonate analogs'20087,427,624'Purine nucleoside phosphorylase inhibitory phosphonate compounds'20087,427,636'Inosine monophosphate dehydrogenase inhibitory phosphonate compounds'20087,417,055'Kinase inhibitory phosphonate analogs'20087,407,965'Phosphonate analogs for treating metabolic diseases'20087,300,924'Anti-infective phosphonate analogs'20077,056,917'Drug efflux pump inhibitor'20066,689,782'Fungal efflux pump inhibitors'20046,399,629'Efflux pump inhibitors'20026,313,127'Heterocyclic compounds useful as pharmaceutical agents'20015,410,064'Heterocyclic acids'19955,214,165'Compounds useful as intermediates in the synthesis of shikimic acid derivatives'19935,164,382'6-Fluoro-shikimic acid derivatives, pharmaceutical compositions and use as antibacterials and fungicides'1992

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1992–2001Based in Macclesfield, GB· patent location history
1995Based in Marton, NZ· patent location history
2002–2011Based in Sunnyvale, CA, US· patent location history
2007–2021Patents assigned to GILEAD SCIENCES INC (68)· patent assignee history
2012–2014Patents assigned to WATKINS WILLIAM J (12)· patent assignee history
2012–2014Patents assigned to CANALES EDA (8)· patent assignee history
2012–2014Patents assigned to LAZERWITH SCOTT E (8)· patent assignee history
2012–2021Based in Saratoga, CA, US· patent location history
2012Based in Foster City, CA, US· patent location history
2013–2014Patents assigned to CHONG LEE S (7)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
GILEAD SCIENCES INC682007–2021
WATKINS WILLIAM Jself122012–2014
CANALES EDA82012–2014
LAZERWITH SCOTT E82012–2014
CHONG LEE S72013–2014
Locations
LocationPatentsSpan
Saratoga, California, US572012–2021
Sunnyvale, California, US152002–2011
Macclesfield, GB31992–2001
Foster City, California, US22012
Marton, NZ11995